1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | An additional appointment on 07/25/2025 was also missed due to transportation issues and a scheduling conflict with R1’s neurologist appointment; no follow-up or rescheduling was conducted by the facility. Furthermore, R1 had an appointment on 08/25/2025, which was missed due to a change in R1’s condition, and no attempt was made by the Administrator Aliti to reschedule. Confirmation from the clinic indicated that there were no completed encounters or rescheduled appointments for these missed visits. Moreover, a review of R1’s external referral form dated 06/19/2025 revealed that R1 had stopped following up with their neurology provider, and now that the office is closed a new referral will be submitted.
It was also learned that R1 was hospitalized on 11/06/2025 and discharged on 11/14/2025 with a change in condition, including a special diet of mechanical soft diet. A review of R1’s LIC 603A (Resident Appraisal) and LIC 625 (Needs and Services Plan) revealed that these documents were not updated to reflect R1’s change in condition. Additionally, it was learned that in the days leading up to hospitalization, R1 experienced a rapid and significant decline from baseline, including excessive mucus production resulting in choking episodes during sleep. Despite these symptoms, R1 was not promptly taken to the hospital or referred to a primary care provider, and this change in condition was not documented in facility records until addressed to Administrator Aliti on 01/05/2026. Per the Admission Agreement, the facility is responsible for regularly observing residents’ physical and mental conditions and arranging for incidental medical and dental care services; however, the facility did not meet these obligations.
On 01/06/2026, Licensing Program Analysts (LPAs) Lee and Tamayo reviewed medications for three of ten residents by comparing medications on hand with Medication Administration Records (MARs) and identified discrepancies. MARs were not initial on multiple days, making it unclear whether medications were administered as prescribed or if staff did not document administration. Additionally, medications were not consistently administered in accordance with bubble pack instructions regarding dates and times.
On 02/03/2026, LPAs Lee and Hughes reviewed Resident 2 (R2)’s MAR and observed missing initials for medication administration on 02/01/2026 and 02/02/2026. A review of R2’s medication, Amlodipine 10 mg (take one tablet by mouth daily), with a quantity of 30 tablets, and the Centrally Stored Medication Destruction Record (CSMDR), which indicated a start date of 11/05/2025, revealed discrepancies. Care staff Qadroka conducted a pill count and reported ten (10) tablets remaining, indicating inconsistencies in medication tracking. A review of R1’s MARs from October through January also showed discrepancies.
CONTINUED LIC 9099-C |